422

Ranbaxy on Wednesday said that it has settled the long-running dispute with Pfizer on the cholesterol-fighting drug, Lipitor, which is also among the world s highest selling drug.The value accruing to Ranbaxy is seen exceeding $1.5 billion, say sources. This is also one of the biggest settlement in the global pharma industry. The settlement covers key markets in eight countries, including the US.

drug, global, india, lipitor, ndtv, pfizer, pharma, ranbaxy, profit,